1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,195 | 4,255 | 20.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.08. | Paxman AB: Paxman Announces FDA Regulatory Progress for Limb Cryocompression System | 128 | GlobeNewswire (Europe) | Paxman today announces a significant regulatory milestone in the development of its Limb Cryocompression System for the reduction of chemotherapy-induced peripheral neuropathy (CIPN), with the U.S.... ► Artikel lesen | |
| 22.05. | Paxman AB: Press release from PAXMAN AB's 2026 Annual General Meeting | 378 | GlobeNewswire (Europe) | PAXMAN's AGM was held today, 22 May 2026, in Karlshamn. Almost 36,4 % of all issued shares were represented at the meeting. After the formal AGM, CEO Richard Paxman gave a digital company presentation... ► Artikel lesen | |
| PAXMAN Aktie jetzt für 0€ handeln | |||||
| 21.05. | Paxman AB: PAXMAN publishes its interim report for Q1 2026 | 245 | GlobeNewswire (Europe) | Figures in parentheses refer to the outcome for the corresponding period of the previous year. Dignitana has been part of the group since June 1 2025.
The Group's sales amounted to 89.6 (67.1) MSEK... ► Artikel lesen | |
| 27.02. | Paxman AB: PAXMAN publishes year-end report as of 31 December 2025 | 857 | GlobeNewswire (Europe) | Strategic investments support future growth!
Figures in parentheses refer to the outcome for the corresponding period of the previous year.The Group's net sales amounted to 84.4 (66.2) MSEK for the... ► Artikel lesen | |
| 20.02. | Paxman AB: Paxman Announces Category III CPT Codes for Cryocompression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy | 804 | GlobeNewswire (Europe) | Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III CPT® codes describing the... ► Artikel lesen | |
| 14.11.25 | Paxman AB: PAXMAN publishes its interim report for Q3 2025 | 444 | GlobeNewswire (Europe) | First full post acquisition quarter builds momentum for 2026
(Dignitana has been part of the group since June 1. Figures in parentheses refer to the outcome for the corresponding period of the previous... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 59,53 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 46,215 | -0,92 % | PRESSESPIEGEL/Unternehmen: PORSCHE, FRANKFURTER LEBEN/DWS, FRESENIUS KABI, ANTHROPIC, LEGORA | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
PORSCHE - Der Sportwagenbauer Porsche plant nach Informationen der Wirtschaftswoche... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,810 | -0,43 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BILLIONTOONE | 95,27 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,890 | -0,10 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,970 | 0,00 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| HEARTFLOW | 46,760 | -0,09 % | Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds Stand | ||
| CARL ZEISS MEDITEC | 32,140 | -0,31 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| ALIGNMENT HEALTHCARE | 12,930 | 0,00 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| BETA BIONICS | 19,490 | +0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,705 | -0,12 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,660 | +0,08 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 6,540 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| PROGYNY | 25,980 | +0,08 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| GENEDX | 82,62 | +0,08 % | GeneDx launches online exome testing for pediatric patients |
Das Unternehmen PAXMAN AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,59 % bei einem Aktienkurs von 4,035 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PAXMAN AB finden Sie auf Wallstreet Online.